Schedule 13G ownership disclosure

CATALYST PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 14888U101

Event date: 2019-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,673,954
Percent of class
4.5400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-19-003054
Form type
SC 13G/A
Filer
CATALYST PHARMACEUTICALS, INC.
CIK
CIK 1369568
Filed
Dec 09, 2019
Reporting period
Nov 30, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub